Sign Out
TAZPEN is indicated for the treatment of systemic and/or local bacterial infections caused by susceptible organisms (detected/suspected) in the conditions listed as follows: Lower respiratory tract infections; Urinary tract infections (complicated and uncomplicated); Intra-abdominal infections; Skin and skin structure infections; Bacterial septicaemia; Polymicrobic infections including those where aerobic and anaerobic organisms are suspected (intra-abdominal, skin and skin structure, lower respiratory tract); Bacteria infections in neutropenic adults or children (in combination with an aminoglycoside).
Antimicrobial therapy should be adjusted, if appropriate, once the results of culture(s) and antimicrobial susceptibility testing are known.
